AU722147B2 - N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics - Google Patents

N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics Download PDF

Info

Publication number
AU722147B2
AU722147B2 AU44638/97A AU4463897A AU722147B2 AU 722147 B2 AU722147 B2 AU 722147B2 AU 44638/97 A AU44638/97 A AU 44638/97A AU 4463897 A AU4463897 A AU 4463897A AU 722147 B2 AU722147 B2 AU 722147B2
Authority
AU
Australia
Prior art keywords
general formula
compound
disorders
disease
piperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU44638/97A
Other languages
English (en)
Other versions
AU4463897A (en
Inventor
Gihad Dargazanli
Jonathan Frost
Pascal George
Patrick Lardenois
Pascale Magat
Maria-Carmen Renones
Johannes Schoemaker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of AU4463897A publication Critical patent/AU4463897A/en
Application granted granted Critical
Publication of AU722147B2 publication Critical patent/AU722147B2/en
Assigned to SANOFI-SYNTHELABO reassignment SANOFI-SYNTHELABO Amend patent request/document other than specification (104) Assignors: SYNTHELABO
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AU44638/97A 1996-10-01 1997-09-26 N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics Ceased AU722147B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR96/11925 1996-10-01
FR9611925A FR2753970B1 (fr) 1996-10-01 1996-10-01 Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique
PCT/FR1997/001692 WO1998014444A1 (fr) 1996-10-01 1997-09-26 Derives de n-(benzothiazol-2-yl)piperidine-1-ethanamine, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
AU4463897A AU4463897A (en) 1998-04-24
AU722147B2 true AU722147B2 (en) 2000-07-20

Family

ID=9496217

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44638/97A Ceased AU722147B2 (en) 1996-10-01 1997-09-26 N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics

Country Status (23)

Country Link
EP (1) EP0929550A1 (hu)
JP (1) JP2001501217A (hu)
KR (1) KR20000048767A (hu)
CN (1) CN1230959A (hu)
AR (1) AR009105A1 (hu)
AU (1) AU722147B2 (hu)
BG (1) BG103271A (hu)
BR (1) BR9711842A (hu)
CA (1) CA2266510A1 (hu)
CO (1) CO4650030A1 (hu)
CZ (1) CZ112699A3 (hu)
EE (1) EE9900135A (hu)
FR (1) FR2753970B1 (hu)
HU (1) HUP9904091A3 (hu)
IL (1) IL128902A (hu)
NO (1) NO991581L (hu)
NZ (1) NZ334553A (hu)
PL (1) PL332648A1 (hu)
SK (1) SK42299A3 (hu)
TR (1) TR199900634T2 (hu)
TW (1) TW438800B (hu)
WO (1) WO1998014444A1 (hu)
ZA (1) ZA978772B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9725541D0 (en) * 1997-12-02 1998-02-04 Pharmacia & Upjohn Spa Amino-benzothiazole derivatives
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
MXPA02012596A (es) * 2000-06-21 2003-04-10 Hoffmann La Roche Derivados de benzotiazol.
US7087761B2 (en) 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
MXPA06004304A (es) * 2003-10-24 2006-06-05 Hoffmann La Roche Antagonistas del receptor ccr-3.
JP4668265B2 (ja) 2004-05-24 2011-04-13 エフ.ホフマン−ラ ロシュ アーゲー 4−ヒドロキシ−4−メチル−ピペリジン−1−カルボン酸(4−メトキシ−7−モルホリン−4−イル−ベンゾチアゾール−2−イル)−アミド
ATE400557T1 (de) 2004-11-05 2008-07-15 Hoffmann La Roche Verfahren zur herstellung von isonikotinsäurederivaten
MX2007011483A (es) 2005-03-23 2007-10-12 Hoffmann La Roche Derivados de acetilenil-pirazolo-pirimidina como antagonistas de glutamato metabotropico 2.
CA2623721C (en) 2005-09-27 2014-05-13 F. Hoffmann-La Roche Ag Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법

Also Published As

Publication number Publication date
IL128902A (en) 2001-07-24
AU4463897A (en) 1998-04-24
BR9711842A (pt) 1999-08-24
SK42299A3 (en) 1999-12-10
NO991581D0 (no) 1999-03-30
HUP9904091A3 (en) 2000-07-28
WO1998014444A1 (fr) 1998-04-09
EP0929550A1 (fr) 1999-07-21
CO4650030A1 (es) 1998-09-03
AR009105A1 (es) 2000-03-08
TW438800B (en) 2001-06-07
CZ112699A3 (cs) 1999-06-16
CN1230959A (zh) 1999-10-06
FR2753970B1 (fr) 1998-10-30
IL128902A0 (en) 2000-02-17
CA2266510A1 (en) 1998-04-09
TR199900634T2 (xx) 1999-06-21
KR20000048767A (ko) 2000-07-25
BG103271A (en) 2000-05-31
NO991581L (no) 1999-06-01
HUP9904091A2 (hu) 2000-05-28
NZ334553A (en) 2000-11-24
PL332648A1 (en) 1999-09-27
ZA978772B (en) 1998-03-27
EE9900135A (et) 1999-12-15
JP2001501217A (ja) 2001-01-30
FR2753970A1 (fr) 1998-04-03

Similar Documents

Publication Publication Date Title
JP2756742B2 (ja) N−アシル−2,3−ベンゾジアゼピン誘導体、その製造法、それを含有する医薬組成物、およびその製造法
CA2398794C (en) 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
US10508102B2 (en) Inhibitors of cellular necrosis and related methods
RU2167152C2 (ru) N-замещенные азагетероциклические карбоновые кислоты или их фармацевтически приемлемые соли, способ их получения, фармацевтическая композиция на их основе и способ ингибирования нейрогенного воспаления
EP0610793A1 (en) Tetracyclic morpholine derivatives and their use or analgesics
PL213669B1 (pl) Pochodna 2-okso-1-pirolidyny, srodek farmaceutyczny i zastosowanie pochodnej 2-okso-1-pirolidyny
JP2005537293A (ja) N−[フェニル(ピペリジン−2−イル)メチル]ベンズアミド誘導体、その製造法、およびその治療用途
US4879300A (en) Novel piperidine derivatives
JPS63146874A (ja) インドール誘導体
AU722147B2 (en) N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics
JP2004504323A (ja) インドロキナゾリノン類
US5834482A (en) Heterocyclic chemistry
JPH02178263A (ja) アザアズレン誘導体、その製造法およびそれを有効成分とする抗アレルギー剤および抗炎症剤
PT2297148E (pt) Novos derivados de (piperazinilo em ponte)-1-alcanona e sua utilização como inibidores de p75
EP0537993A1 (en) Nicotinic activity of a series of arecolones and isoarecolones
NZ226681A (en) Diazepinone derivatives: preparatory processes and pharmaceutical compositions
ES2217533T3 (es) Derivados de indolomorfinano y medicamentos/preventivos para transtornos cerebrales.
TW498073B (en) 5-naphthalen-1-yl-1,3-dioxane derivatives, their preparation and their therapeutic application
WO1988002751A1 (en) Pyridine derivatives
JPH0240381A (ja) 新規縮合ジアゼピノン類、それらの製造方法及びこれらの化合物を含有する医薬組成物
WO2006129781A1 (ja) ジベンズオキセピン誘導体の製造方法
JPH05247052A (ja) N−アルキルグルタールイミドの4−(4−ピペリジニル)−チエノ〔3,2−c〕ピリジン誘導体
TW206230B (hu)
JPH06228095A (ja) カルバゾール誘導体
MXPA99003078A (en) N

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: SANOFI-SYNTHELABO

Free format text: FORMER NAME: SYNTHELABO

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired